At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LINE Lineage
Pre-Mkt 08-24 07:10:59 EDT
41.61
+0.15
+0.36%
High42.02Low41.48Vol387.71K
Open42.02D1 Closing41.46Amplitude1.30%
Mkt Cap9.45BTradable Cap2.38BTotal Shares227.08M
T/O16.16MT/O Rate0.68%Tradable Shares57.19M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)
TIPRANKS  ·  08-20
Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)
KARMAN LINE ACQUISITION CORP. Announces Pricing of $200 Million Initial Public Offering
GlobeNewswire  ·  08-18
KARMAN LINE ACQUISITION CORP. Announces Pricing of $200 Million Initial Public Offering
Lineage Seen Benefiting From Improving Industry Conditions, RBC Capital Markets Says
MT Newswires Live  ·  08-17
Lineage Seen Benefiting From Improving Industry Conditions, RBC Capital Markets Says
RBC Raises Price Target on Lineage to $48 From $44, Keeps Outperform Rating
MT Newswires Live  ·  08-17
RBC Raises Price Target on Lineage to $48 From $44, Keeps Outperform Rating
Lineage, Inc. : RBC Raises Target Price to $48 from $44
THOMSON REUTERS  ·  08-17
Lineage, Inc. : RBC Raises Target Price to $48 from $44
Should Widening Losses Despite Higher Sales in Q2 2026 Require Action From Lineage (LINE) Investors?
Simply Wall St.  ·  08-16
Should Widening Losses Despite Higher Sales in Q2 2026 Require Action From Lineage (LINE) Investors?
Lineage is Maintained at Neutral by Citigroup
Dow Jones  ·  08-14
Lineage is Maintained at Neutral by Citigroup
Lineage Maintained at Buy with Unchanged $3 Target as Cell Therapy Pipeline and DOSED SCI Trial Advance
TIPRANKS  ·  08-13
Lineage Maintained at Buy with Unchanged $3 Target as Cell Therapy Pipeline and DOSED SCI Trial Advance
Lineage CFO Robb LeMasters Buys 20,000 Shares for $826,638
Reuters  ·  08-11
Lineage CFO Robb LeMasters Buys 20,000 Shares for $826,638
Lineage, Inc. Earnings Call Signals Cautious Upside
TIPRANKS  ·  08-10
Lineage, Inc. Earnings Call Signals Cautious Upside
Stronger NOI Guidance Amid Wider Losses Could Be A Game Changer For Lineage (LINE)
Simply Wall St.  ·  08-08
Stronger NOI Guidance Amid Wider Losses Could Be A Game Changer For Lineage (LINE)
Lineage Cell Therapeutics Balances Progress and Risk
TIPRANKS  ·  08-08
Lineage Cell Therapeutics Balances Progress and Risk
Lineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c)
TIPRANKS  ·  08-07
Lineage Cell Therapeutics reports Q2 EPS (3c), consensus (3c)
Lineage Cell Therapeutics Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.069M Miss $1.531M Estimate
Benzinga Earnings  ·  08-07
Lineage Cell Therapeutics Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $1.069M Miss $1.531M Estimate
Press Release: Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Dow Jones  ·  08-07
Press Release: Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and Lineage, Inc. (LINE)
TIPRANKS  ·  08-06
Analysts Offer Insights on NA Companies: GRAIL Inc (GRAL) and Lineage, Inc. (LINE)
Lineage price target raised to $43 from $40 at Baird
TIPRANKS  ·  08-06
Lineage price target raised to $43 from $40 at Baird
Lineage, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  08-05
Lineage, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary
Lineage raises FY26 AFFO view to $2.80-$3.05 from $2.75-$3.00
TIPRANKS  ·  08-05
Lineage raises FY26 AFFO view to $2.80-$3.05 from $2.75-$3.00
Lineage Publishes Investor Presentation on Global Temperature-Controlled Warehouse REIT Strategy and Scale
Reuters  ·  08-05
Lineage Publishes Investor Presentation on Global Temperature-Controlled Warehouse REIT Strategy and Scale

Introduction

Company Name.
Lineage
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--